Sugary Drink Ban + Counseling for Metabolic Health Improvement
(MHIP Trial)
Trial Summary
What is the purpose of this trial?
The purpose of the study is to test the impact of a multilevel workplace intervention (hospital-wide sales ban on sugar-sweetened beverages (SSBs) and individual-level brief counseling) on employee health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Sugary Drink Ban + Counseling for Metabolic Health Improvement?
Research shows that counseling, especially when delivered through motivational interviewing and brief interventions, can lead to positive changes in dietary habits and metabolic health. For example, studies have found that telephone-delivered nutrition education and motivational interviewing can significantly reduce weight, body fat, and improve dietary behaviors, which are important for managing metabolic syndrome.12345
Is the Sugary Drink Ban + Counseling treatment safe for humans?
How is the Sugary Drink Ban + Counseling treatment different from other treatments for metabolic health improvement?
This treatment is unique because it combines a ban on sugary drinks with brief counseling using motivational interviewing, which helps patients set and achieve realistic lifestyle goals. Unlike other treatments that may focus solely on diet or medication, this approach emphasizes behavior change and self-management to improve metabolic health.310111213
Research Team
Laura A Schmidt, Ph.D
Principal Investigator
University of California, San Francisco
Elissa Epel, Ph.D
Principal Investigator
University of California, San Francisco
Jamey Schmidt
Principal Investigator
Sutter Health/California Pacific Medical Center Research Institute
Eligibility Criteria
This trial is for full-time employees at certain Sutter Health sites who drink three or more sugary drinks a week, can speak and read English, and are willing to have two fasting blood tests. Pregnant individuals cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a workplace SSB sales ban and/or brief counseling intervention
Follow-up
Participants are monitored for changes in health metrics such as lipid profile, insulin sensitivity, and BMI
Treatment Details
Interventions
- Brief Intervention
- Workplace SSB sales ban
Brief Intervention is already approved in United States, European Union for the following indications:
- Alcohol misuse in HIV care
- Substance use disorder
- Alcohol misuse
- Substance use disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Sutter Health
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
California Pacific Medical Center Research Institute
Collaborator